Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Latest news on ROCHE HOLDING LTD.
07:28p ROCHE : Special Notice - 66-- Intent to Sole Source / Roche Diagnostic Corporati..
04:31p ROCHE : Ac immune discovers next generation antibodies focused on neurodegenerat..
04:29p Chugai Pharmaceutical Co., Ltd. - New Drug Application Filed for Glycoenginee..
03:46p ROCHE : Stemina Biomarker Discovery Prepares to Commercialize Autism Diagnostic ..
08/21 ROCHE : Special Notice - 65-- Intent to Sole Source / Roche Diagnostic Corporati..
08/18DJCorrection to Biogen Treads Tricky Path Between Politicians, Investors Articl..
08/18 ROCHE : New target could yield treatment for Alzheimer`s, ALS and more
08/17 ROCHE : Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Cla..
08/16 FIBROGEN : Galapagos and FibroGen drugs offer hope in IPF
08/16 FOUNDATION MEDICINE : Cancer Treatment Centers of America and Foundation Medicin..
08/15 ROCHE : Acquires MySugr
08/15 CHUGAI PHARMACEUTICAL : Announcement of a Commencement of Arbitration against Ch..
08/15DJROCHE : Drug-Trial Previews Burn Investors -- WSJ
08/14 ROCHE : Special Notice - 66-- Intent to Sole Source / Roche Diagnostics Corporat..
08/14DJROCHE : Some Investors Feel Burned by Drugmakers' Clinical-Trial Reports
08/12 ROCHE : KIT, solution and material, compatible with use in blood and PH hemogaso..
08/11 ESSEX BIO TECHNOLOGY : Ac immune reports second quarter 2017 financial results
08/11 INSIDER TRADING ACTIVITY FOUNDATION : FMI) – Director Sold 30,000 shares ..
08/11 INSIDER TRADING ACTIVITY FOUNDATION : FMI) – Insider Sold 46,872 shares o..
08/11 INSIDER TRADING ACTIVITY FOUNDATION : FMI) – Director Sold 4,800 shares o..
08/10 Khang & Khang LLP Announces Securities Class Action Lawsuit against Foundatio..
08/10 Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit aga..
08/10 ROCHE : Clinical Nurse Leader Concentration Added to La Roche's MSN Program
08/10 ROCHE : Daiichi`s Plexxikon goes after Novartis cancer med Tafinlar in BRAF pate..
08/10 Roche out-licenses lebrikizumab rights to Dermira
08/10 ROCHE : Analysis services
08/09 ROCHE : A better life in Cornwall
08/09 DERMIRA : Gains Rights to Roche IL-13 Inhibitor Lebrikizumab in Up-to-$1.4B Part..
08/09 ROCHE : sells off its struggling IL-13 drug lebrikizumab in $1.4B Dermira deal
08/09 INSIDER TRADING ACTIVITY FOUNDATION : FMI) – Director Sold 18,072 shares ..
08/08 ROCHE : Genentech - FDA Grants Priority Review and Breakthrough Therapy Designat..
08/08 DERMIRA, INC. (NASDAQ : DERM) Files An 8-K Entry into a Material Definitive Agre..
08/08 NATCO PHARMA : NET UP AT Rs93.7 CRORE
08/08 FOUNDATION MEDICINE : $-0.17 EPS Expected for Universal Business Payment Solutio..
08/08 ROCHE : FDA Grants Priority Review and Breakthrough Therapy Designation for Zelb..
08/07 ROCHE HOLDING LTD. : DEADLINE TODAY: Khang & Khang LLP Announces Securities Clas..
08/07 ROCHE HOLDING LTD. : DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders ..
08/07 ROCHE HOLDING LTD. : FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Re..
08/07 ROCHE : FDA Grants Priority Review and Breakthrough Therapy Designation for Zelb..
08/05 ROCHE HOLDING LTD. : DEADLINE MONDAY: Lundin Law PC Announces Securities Class A..
08/04 ROCHE : Insurance services
08/04 ROCHE HOLDING LTD. : RHHBY DEADLINE ALERT: The Law Offices of Vincent Wong Remin..
08/04 ROCHE : working to identify treatment options for lung cancer patients
08/04 ROCHE : UK NICE invites Roche to submit Cancer Drugs Fund proposal for atezolizu..
08/04 ROCHE : UKs NICE invites Roche to submit CDF proposal for urothelial cancer drug
08/04 ROCHE : NICE invites Roche to submit Tecentriq for CDF
08/04 ROCHE : Genentech - FDA Grants Genentech's Alecensa Priority Review for Initial ..
08/04 ROCHE : Refuse and waste related services
08/03 ROCHE HOLDING LTD. : 4-DAY DEADLINE: Khang & Khang LLP Announces Securities Clas..
08/03 ACCENTURE : to Transform Diabetic Patient Care Using Data-driven Analytics Platf..
08/03 FOUNDATION MEDICINE : Findings from Foundation Medicine Inc. in Oncology Reporte..
08/03 SEATTLE GENETICS : Announces Clinical Collaboration to Expand the Therapeutic Ev..
08/03 ROCHE HOLDING LTD. : The Klein Law Firm Reminds Investors of a Class Action File..
08/03 HOW NOVARTIS AG (ADR) (NYSE : NVS) Uses Proceeds From Asset Sales Would Determin..
08/03 ROCHE : NICE - Share, Roche invited to submit a CDF proposal for urothelial canc..
08/03 ROCHE : Theravance Biopharma Appoints Shehnaaz Suliman, MD, as Senior Vice Presi..
08/03 ROCHE : FDA grants Roche’s Alecensa Priority Review for initial treatment ..
08/03 ROCHE : FDA Grants Genentech’s Alecensa Priority Review for Initial Treatm..
08/02 ROCHE HOLDING LTD. : Levi & Korsinsky, LLP Reminds Shareholders of Roche Holding..
08/01 FOUNDATION MEDICINE : reports 2Q loss
08/01 FOUNDATION MEDICINE, INC. (NASDAQ : FMI) Files An 8-K Entry into a Material Defi..
08/01 FOUNDATION MEDICINE, INC. : Entry into a Material Definitive Agreement, Results ..
08/01 ROCHE : to showcase power of connected lab at AACC 2017 Clinical Lab Expo
07/30 ROCHE : CRICKET-YODI-SCOREBOARD Zimbabwe U19s vs Windies U19s - 3rd game
07/29 ROCHE : Sausage products
07/28 SENSEONICS : Roche partners with Senseonics, TypeZero on artificial pancreas
07/28 ROCHE : FDA grants breakthrough therapy designation for Venclexta in acute myelo..
07/28 ROCHE : raises outlook for 2017 following strong launches
07/27 CHUGAI PHARMACEUTICAL REPORTS FINDIN : their identification and pharmacological ..
07/27 ROCHE HOLDING LTD. : UPCOMING DEADLINE: Lundin Law PC Announces Securities Class..
07/27 ROCHE HOLDING LTD. : Levi & Korsinsky, LLP Reminds Shareholders of Roche Holding..
07/27 ROCHE : antibody becomes first of its kind authorised for blood cancer
07/27 SENSEONICS : Roche joins quest to create closed loop insulin device
07/27 AstraZeneca slump dominates European shares on busy earnings day
07/27 ROCHE : NICE backs Cancer Drugs Fund support for Roche`s Gazyvaro
1  2  3  4  5  6  7  8  9  10Next
Financials ( CHF)
Sales 2017 53 295 M
EBIT 2017 18 366 M
Net income 2017 11 164 M
Debt 2017 8 833 M
Yield 2017 3,53%
P/E ratio 2017 18,21
P/E ratio 2018 16,57
EV / Sales 2017 4,13x
EV / Sales 2018 3,90x
Capitalization 211 493 M
Chart ROCHE HOLDING LTD.
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders
Technical analysis trends ROCHE HOLDING LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 30
Average target price 280  CHF
Spread / Average Target 15%
EPS Revisions
Managers
NameTitle
Severin Schwan Chief Executive Officer & Executive Director
Christoph Franz Chairman
Alan Hippe Chief Financial & Information Technology Officer
John Irving Bell Non-Executive Director
Andreas Oeri Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
ROCHE HOLDING LTD.3.78%218 387
JOHNSON & JOHNSON15.83%361 535
NOVARTIS7.89%219 476
PFIZER2.06%197 412
MERCK AND COMPANY6.03%170 241
SANOFI6.97%122 091